Cost-effectiveness of new cytology technologies
Hutchinson, M.; Farber, F.L.
American Journal of Clinical Pathology 113(1): 149-151
2000
ISSN/ISBN: 0002-9173 PMID: 10631869 Document Number: 518123
Document emailed within 1 workday
Related Documents
AuBuchon, J.P. 2000: Cost-effectiveness of new blood safety technologies Developments in Biologicals 102: 211-215Lumachi, F.; Basso, S.M.M.; Borsato, S.; Tregnaghi, A.; Zucchetta, P.; Marzola, M.Cristina.; Cecchin, D.; Bui, F.; Favia, G.; Fabia, G. 2005: Role and cost-effectiveness of adrenal imaging and image-guided FNA cytology in the management of incidentally discovered adrenal tumours Anticancer Research 25(6c): 4559-4562
Splett, P.L. 1991: Phase I: status report of existing data on the effectiveness, cost, and cost effectiveness of nutrition care services Journal of the American Dietetic Association Suppl: S9-14
Splett, P.L. 1991: Phase I: status report of existing data on the effectiveness, cost, and cost effectiveness of nutrition care services Journal of the American Dietetic Association Suppl: S9-14
Shade, S.B.; Kevany, S.; Onono, M.; Ochieng, G.; Steinfeld, R.L.; Grossman, D.; Newmann, S.J.; Blat, C.; Bukusi, E.A.; Cohen, C.R. 2013: Cost, cost-efficiency and cost-effectiveness of integrated family planning and HIV services Aids 27(Suppl 1): S87-S92
Kahn, J.G.; Jiwani, A.; Gomez, G.B.; Hawkes, S.J.; Chesson, H.W.; Broutet, N.; Kamb, M.L.; Newman, L.M. 2014: The cost and cost-effectiveness of scaling up screening and treatment of syphilis in pregnancy: a model PLOS one 9(1): E87510
Mielck, A. 1988: Cost-effectiveness and cost-benefit approaches in programs designed to prevent AIDS Aids and Public Policy Journal 3(3): 19-22
Hudecková, H.; Straka, S.; Szilágyiová, M.; Avdicová, M.; Rusnáková, S. 2002: Cost effectiveness and cost benefit of viral hepatitis B vaccination in the Slovak Republic Central European Journal of Public Health 10(4): 146-148
Deirdre Wulf 1981: Cost-Benefit and Cost-Effectiveness Analysis for Family Planning Programs International Family Planning Perspectives 7(4): 141-144
Drummond, M.F. 1985: Survey of cost-effectiveness and cost-benefit analyses in industrialized countries World Health Statistics Quarterly. Rapport Trimestriel de Statistiques Sanitaires Mondiales 38(4): 383-401
Walker, D. 2003: Cost and cost-effectiveness of HIV/AIDS prevention strategies in developing countries: is there an evidence base? Health Policy and Planning 18(1): 4-17
Di Pasquale, C. 1983: Various methods for community fluoridation--the situation in Africa. (A comparative study on cost benefits and cost effectiveness.) Odonto-Stomatologie Tropicale 6(1): 7-18
Granich, R.; Kahn, J.G.; Bennett, R.; Holmes, C.B.; Garg, N.; Serenata, C.; Sabin, M.Lewis.; Makhlouf-Obermeyer, C.; De Filippo Mack, C.; Williams, P.; Jones, L.; Smyth, C.; Kutch, K.A.; Ying-Ru, L.; Vitoria, M.; Souteyrand, Y.; Crowley, S.; Korenromp, E.L.; Williams, B.G. 2012: Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050 PloS one 7(2): e30216
Marseille, E.; Giganti, M.J.; Mwango, A.; Chisembele-Taylor, A.; Mulenga, L.; Over, M.; Kahn, J.G.; Stringer, J.S.A. 2012: Taking ART to scale: determinants of the cost and cost-effectiveness of antiretroviral therapy in 45 clinical sites in Zambia Plos one 7(12): E51993
Bassett, I.V.; Govindasamy, D.; Erlwanger, A.S.; Hyle, E.P.; Kranzer, K.; van Schaik, N.; Noubary, F.; Paltiel, A.D.; Wood, R.; Walensky, R.P.; Losina, E.; Bekker, L.-G.; Freedberg, K.A. 2014: Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectiveness Plos one 9(1): E85197
Wessels, F.; Anderson, A.N.; Kropman, K. 1999: The cost-effectiveness of isotretinoin in the treatment of acne. Part 3. a cost-minimisation pharmaco-economic model South African Medical Journal 89(7 Part 2): 791-794
Kawalec, P.ł; Holko, P.ła.; Szkultecka-Debek, M.; Paszulewicz, A.; Boratyńska, M.; Głyda, M.; Ignacak, E.; Maks, J.; Russel-Szymczyk, M.; Kaweczyńska-Lasoń, A. 2013: The evaluation of cost-effectiveness and cost-utility of valganciclovir for the prophylaxis of cytomegalovirus disease to 200 days after kidney transplantation Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 34(204): 332-338
Gomez, G.B.; Borquez, A.; Case, K.K.; Wheelock, A.; Vassall, A.; Hankins, C. 2013: The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies Plos Medicine 10(3): E1001401
Chhagan, M.K.; Van den Broeck, J.; Luabeya, K-Kany.Angelique.; Mpontshane, N.; Bennish, M.L. 2014: Cost of childhood diarrhoea in rural South Africa: exploring cost-effectiveness of universal zinc supplementation Public Health Nutrition 17(9): 2138-2145
Babagoli, M.A.; Benshaul-Tolonen, A.; Zulaika, G.; Nyothach, E.; Oduor, C.; Obor, D.; Mason, L.; Kerubo, E.; Ngere, I.; Laserson, K.F.; Tudor Edwards, R.; Phillips-Howard, P.A. 2022: Cost-Effectiveness and Cost-Benefit Analyses of Providing Menstrual Cups and Sanitary Pads to Schoolgirls in Rural Kenya Women's Health Reports 3(1): 773-784